CXCL13 Promotes Osteogenic Differentiation of Mesenchymal Stem Cells by Inhibiting miR-23a Expression

CXC chemokines are essential for osteogenic differentiation of bone mesenchymal stem cells (BMSCs) for use in bone tissue engineering and regenerative medicine in clinical settings. However, an accurate understanding of the underlying mechanisms is still needed. In this study, we analyzed the effect...

Descripción completa

Detalles Bibliográficos
Autores principales: Tian, Feng, Ji, Xiang-lu, Xiao, Wan-an, Wang, Bin, Wang, Fei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2015
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4345275/
https://www.ncbi.nlm.nih.gov/pubmed/25784941
http://dx.doi.org/10.1155/2015/632305

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4345275/
https://www.ncbi.nlm.nih.gov/pubmed/25784941
http://dx.doi.org/10.1155/2015/632305

Ejemplares similares